Potential recruitment into a clinical trial of vascular secondary prevention medications in cerebral small vessel disease, based on concomitant medication use

BACKGROUND: Blood pressure-lowering medications, antiplatelet drugs and statins are often prescribed to asymptomatic patients with white matter hyperintensities (WMH). A clinical trial is needed, but potential trial participants would be excluded if they already had another indication to take the me...

Descripción completa

Detalles Bibliográficos
Autores principales: Morrison, Edward, Lyall, Donald M, Pell, Jill P., Mackay, Daniel F., Doubal, Fergus N., Wardlaw, Joanna M., Quinn, Terence, Makin, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616395/
https://www.ncbi.nlm.nih.gov/pubmed/36324721
http://dx.doi.org/10.1016/j.cccb.2021.100015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616395/
https://www.ncbi.nlm.nih.gov/pubmed/36324721
http://dx.doi.org/10.1016/j.cccb.2021.100015

Ejemplares similares